THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, has been invited to deliver a presentation at The Phacilitate Cell & Gene Therapy Forum Asia 2011 at the Marina Bay Sands Hotel in Singapore. This year’s Forum, which is taking place on September 19, 2011, is titled Delivering the Strategic Keys to Capitalizing on World-class Cell & Gene Therapy Manufacturing Opportunities in Asia & Australia. Mr. Warma’s presentation will occur at 12:40 PM Singapore time.
